We are live on
!
Find out more
Victory Capital Management Portfolio holdings
AUM
$178B
1-Year Est. Return
37.23%
This Fund
S&P 500
This Quarter
Est. Return
-1.67%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$100B
AUM Growth
-$8.74B
(-8%)
Cap. Flow
-$1.7B
Cap. Flow
% of AUM
-1.7%
Top 10 Holdings %
Top 10 Hldgs %
9.77%
Holding
2,893
New
146
Increased
1,494
Reduced
995
Closed
170
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MKS Inc
MKSI
|
+$219M |
| 2 |
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
|
+$185M |
| 3 |
Ross Stores
ROST
|
+$144M |
| 4 |
Progressive
PGR
|
+$134M |
| 5 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.49B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$762M |
| 3 |
Vanguard Total World Stock ETF
VT
|
+$476M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$348M |
| 5 |
Archer Daniels Midland
ADM
|
+$250M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.9% |
| 2 | Industrials | 13.89% |
| 3 | Financials | 12.91% |
| 4 | Consumer Discretionary | 10.69% |
| 5 | Healthcare | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Applied Industrial Technologies
AIT
$13.3B
| $147M | 0.15% |
1,435,473
-47,271
| -3% | -$4.71M |
|
152
Microchip Technology
MCHP
$46B
| $147M | 0.15% |
2,252,296
+116,083
| +5% | +$8.74M |
|
153
Bristol-Myers Squibb
BMY
$132B
| $147M | 0.15% |
1,946,923
+624,610
| +47% | +$41.9M |
|
154
iShares Core US Aggregate Bond ETF
AGG
$138B
| $145M | 0.15% |
1,411,039
+264,445
| +23% | +$29.1M |
|
155
UMB Financial
UMBF
$11.1B
| $145M | 0.14% |
1,491,101
-168,130
| -10% | -$17.2M |
|
156
Synopsys
SNPS
$79.7B
| $144M | 0.14% |
452,118
+3,846
| +0.9% | +$1.2M |
|
157
Mattel
MAT
$4.23B
| $143M | 0.14% |
6,441,573
+1,738,590
| +37% | +$39.8M |
|
158
ConocoPhillips
COP
$141B
| $141M | 0.14% |
1,470,109
-285,315
| -16% | -$26.2M |
|
159
iShares MSCI Canada ETF
EWC
$6.33B
| $141M | 0.14% |
3,808,076
+2,030,686
| +114% | +$78.5M |
|
160
Bank of America
BAC
$442B
| $140M | 0.14% |
3,822,373
-253,077
| -6% | -$11.4M |
|
161
Crane NXT
CXT
$3.07B
| $139M | 0.14% |
3,705,428
-1,359,395
| -27% | -$48.9M |
|
162
Burlington
BURL
$23.2B
| $139M | 0.14% |
700,563
-72,231
| -9% | -$15.8M |
|
163
Vertex Pharmaceuticals
VRTX
$126B
| $138M | 0.14% |
521,538
+351,044
| +206% | +$83.3M |
|
164
IBM
IBM
$224B
| $137M | 0.14% |
1,038,302
-25,916
| -2% | -$3.38M |
|
165
Verisk Analytics
VRSK
$25B
| $137M | 0.14% |
669,723
+9,789
| +1% | +$1.93M |
|
166
Gilead Sciences
GILD
$165B
| $137M | 0.14% |
2,302,263
+403,107
| +21% | +$25.8M |
|
167
Varonis Systems
VRNS
$5B
| $136M | 0.14% |
2,860,153
-74,595
| -3% | -$3.06M |
|
168
Centene
CNC
$32.5B
| $136M | 0.14% |
1,683,728
-1,105
| -0.1% | -$90.6K |
|
169
Walmart Inc
WMT
$890B
| $136M | 0.14% |
2,661,393
-111,744
| -4% | -$5.25M |
|
170
Agilent Technologies
A
$41.2B
| $135M | 0.14% |
1,132,741
-36,143
| -3% | -$4.97M |
|
171
UFP Industries
UFPI
$5.19B
| $135M | 0.13% |
1,745,897
-49,887
| -3% | -$4.16M |
|
172
Sempra
SRE
$54.8B
| $135M | 0.13% |
1,667,238
+219,990
| +15% | +$15.8M |
|
173
Honeywell
HON
$78B
| $134M | 0.13% |
732,357
+104,668
| +17% | +$19.4M |
|
|
DRE
174
DELISTED
Duke Realty Corp.
DRE
| $133M | 0.13% |
2,303,027
+2,090,991
| +986% | +$118M |
|
175
S&P Global
SPGI
$120B
| $132M | 0.13% |
335,141
+148,906
| +80% | +$60.6M |
|
Similar funds
VGA
Victory Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Victory Capital Management held 2,893 positions worth $100B, down 8% from $109B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Victory Capital Management's Q1 2022 filing shows 146 new, 1,494 increased, 995 reduced and 170 closed positions. Its largest new stake was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.49B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.
- Victory Capital Management's largest Q1 2022 buy was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M.
- Victory Capital Management added most to MKS Inc in Q1 2022, an estimated $219M increase.
- Victory Capital Management's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.49B.
- Victory Capital Management fully exited Vanguard Total World Stock ETF in Q1 2022, selling an estimated $476M.
- Victory Capital Management's ten largest holdings make up 9.8% of its $100B portfolio in Q1 2022.
- Victory Capital Management opened 146 new positions and closed 170 in Q1 2022.
- Victory Capital Management's portfolio value fell 8% quarter-over-quarter to $100B.
Based on Victory Capital Management's 13F filing for Q1 2022, filed 4 May 2022.